China Laws for Imported IVD Reagent Registration Collected in New Report Published at MarketPublishers.com
29 Feb 2012 • by Natalie Aster
LONDON – By the end of 2015, China’s in-vitro diagnostic (IVD) reagent market is likely to reach more than 20.8 billion RMB, attracting more and more in-vitro diagnostic reagents produced abroad. To penetrate such a lucrative market, various overseas in-vitro diagnostic reagents manufacturers and producers should be aware of how to file the application for their imported in-vitro diagnostic reagent registration with Chinese regulatory authorities for in-vitro diagnostic reagents. Also, among other obstacles faced by a variety of these manufacturers and producers one can name the lack of knowledge of the Chinese laws and administrative regulations, the cultural difference between China and Western countries as well as the language barriers.
New research report “China’s Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration” developed by Access China Management Consulting (Access China) provides not only a detailed guidance of practical operation for application and approval of imported in-vitro diagnostic reagent registration but also comprehensive and thorough knowledge of the latest Chinese laws and regulations for imported in-vitro diagnostic reagent registration to guide overseas in-vitro diagnostic reagents manufacturers and producers to pass through the entirely legal procedures of application and approval for imported in-vitro diagnostic reagent registration smoothly.
China’s Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration
Published: March, 2012
Price: US$ 750,00
More new research reports by the publisher can be found at Access China page.